Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Taisho researchers reveal cGMP-dependent phosphodiesterase (PDE V) inhibitors

May 31, 1996

Phase II clinical trial on Gensia's second-generation adenosine-regulating agent commence

May 31, 1996

Gene transfer as treatment for myocardial ischemia

May 31, 1996

Valsartan approved in Germany

May 31, 1996

Endothelin antagonists revealed by Fujisawa

May 31, 1996

FDA to discuss ProAmatine application

May 24, 1996

Na+/K+-ATPase inhibitors disclosed by Sigma-Tau

May 24, 1996

Medco, Fujisawa to codevelop and comarket adenosine for CABG and AMI

May 24, 1996

Transdermal scopolamine studied in hypertensive patients

May 24, 1996

Update on fenoldopam regulatory submission

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...